How have TRLS shares performed in 2024?

Trellus Health's stock was trading at GBX 3.25 at the beginning of 2024. Since then, TRLS stock has decreased by 23.1% and is now trading at GBX 2.50. View the best growth stocks for 2024 here .

How do I buy shares of Trellus Health?

Shares of TRLS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:TRLS

Trellus Health (TRLS) Share Price, News & Analysis

→ Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad)

Free TRLS Stock Alerts

GBX 2.50

+0.50 (+25.00%)

(As of 05:17 AM ET)

Compare

Today's Range: 2.38
▼
2.75
50-Day Range: 1.60
▼
4.25
52-Week Range: 1.50
▼
9.65

Volume: 1.81 million shs
Average Volume: 283,342 shs
Market Capitalization: £4.04 million

P/E Ratio: 250.00
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors

Get Trellus Health alerts:

Ad Banyan Hill Publishing

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

About Trellus Health

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.

TRLS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TRLS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive TRLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trellus Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: LON:TRLS
CUSIP: N/A
CIK: N/A
Web: www.trellushealth.com
Phone: 800-866-4165
Fax: N/A
Employees: 31
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX 0.01
Trailing P/E Ratio: 200.00
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-7,540,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -29.34%
Return on Assets: -17.82%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 34.63
Quick Ratio: 17.11

Sales & Book Value

Annual Sales: £35,000.00
Price / Sales: 92.29
Cash Flow: GBX 2.64 per share
Price / Cash Flow: 0.76
Book Value: GBX 14 per share
Price / Book: 0.14

Miscellaneous

Outstanding Shares: 161,510,000
Free Float: N/A
Market Cap: £3.23 million
Optionable: Not Optionable
Beta: 0.18

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Dr. Marla Cindy Dubinsky M.D.
Co-Founder, CEO & Director
Dr. Laurie Keefer Ph.D.
Co-Founder & Chair of Scientific Advisory Board
Ms. Joy Bessenger B.A.
Chief Financial Officer
Aled Stevenson
Chief Operating Officer
Jamey Hancock
Chief Technology Officer
Amy Murphy
Director of Human Resources
Dr. Andres Jimenez M.B.A.
M.D., M.S., Chief Medical Information Officer
Leah Conley M.B.A.
Head of Global Market Access - Travere Therapeutics & Member of Scientific Advisory Board
Mr. Salim Gulamabbas Hamir F.C.A.
Company Secretary

Key Competitors

View All Competitors

TRLS Stock Analysis - Frequently Asked Questions

How have TRLS shares performed in 2024?: Trellus Health's stock was trading at GBX 3.25 at the beginning of 2024. Since then, TRLS stock has decreased by 23.1% and is now trading at GBX 2.50.
View the best growth stocks for 2024 here.
How do I buy shares of Trellus Health?: Shares of TRLS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:TRLS) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial